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ABSTRACT  
Inspired by the metamorphosis of pore-forming toxins (PFTs) from soluble inactive monomers to 
cytolytic transmembrane assemblies, we developed self-assembly-directed membrane insertion 
of synthetic analogues for permeability alteration. An expanded π-conjugation based molecular 
precursor with extremely high rigidity, long hydrophobic length that comparable to the 
hydrophobic width of plasma membrane, is synthesized for membrane inserted self-assembly. 
Guided by the cancer biomarker expression in vitro, the soluble precursors transform into 
hydrophobic monomers for self-assembly structure inserting into the fluid phase of membrane 
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exclusively. Membrane insertion of rigid synthetic analogue destroys the selective permeability 
of the plasma membrane gradually. It eventually leads to cancer cell death, including drug 
resistant cancer cells. 
INTRODUCTION 
Selective permeability is one of the key features of cell membrane to maintain its functionality 
as active barrier between life and death. Altering the membrane permeability not just leads to cell 
death, but also potentially leads to subtle manipulation of cellular functions. The mechanistic 
insights of membrane targeting proteins enable the development of novel therapeutic strategies. 
Unfortunately, the application of membrane modification and manipulation as part of cancer 
therapy is lagging.1-2 
As a major class of pore-forming proteins, PFTs have been well known for altering the plasma 
membrane permeability of their target cells.3 The targeted surface binding leads to a drastic 
increase in a local concentration triggering the oligomerization of PFTs. Upon the exposure of 
hydrophobic surfaces in the transition process, PFTs insert into membrane leading to cell death. 
These mechanistic insights inspired us to design a potential cancer therapeutic strategy using 
molecular self-assembly facilitated membrane insertion of synthetic analogues on cancer cells. 
As shown in Figure 1, non-toxic water-soluble molecular precursors are constructed to mimic the 
inactive hydrophilic PFT monomers distributed in extracellular fluid. Under tumor 
microenvironment, the alkaline phosphatases (ALPs) that over expressed by cancerous cells 
dephosphorylate the precursors into hydrophobic building blocks upon cell membrane triggering 
self-assembly into rigid aggregates.4-8 The hydrophobic surface of the aggregate facilitates its 
insertion into the hydrocarbon core of membrane constructing nanoarchitectonics among the 
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phospholipid bilayer.9-11 The porosity binding effect with molecules of the inserted synthetic 
analogues lead to membrane permeability alteration by blocking the transportation of molecules. 
Severe permeability alteration eventually leads to cancer cell death. 
 
Figure 1. Schematic illustration of self-assembly directed membrane insertion of long and rigid 
synthetic analogue causing permeability alteration. 
Regarding the complexity and dynamic features of membrane structure, the live cell membrane 
insertion of synthetic analogues, without the help of external force, is difficult and challenging. 
Except single molecular synthetic peptides derived from natural proteins or peptides,12 live cell 
membrane insertion of sub-micron synthetic structures was rarely reported.13 Computational 
simulations indicate that besides intrinsic rigidity of the synthetic analogue, a proper length of 
the purely hydrophobic portion match to the hydrophobic core of the membrane to maximize the 
interactions13 is also critical to the successful insertion.14 Therefore, we select the hydrophobic 
domain of 'muscle molecule',15-16 the expanded π-conjugation system with extremely high rigidity, 
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long linear length, for the construction of desired molecular precursor leading to self-assembly-
guided membrane insertion.  
 
EXPERIMENTAL SECTION 
Materials and Instruments. Ammonium acetate was purchased from Nacalai Tesque, INC. 
and purified by sublimation before usage. Other chemical reagents were purchased from Sigma, 
Nacalai and Wako and used without further purification. Mass spectra were recorded using a 
Thermo LTQ-ETD mass spectrometer (ESI) and high resolution mass spectra were measured 
with a Thermo LTQ-Orbitrap Classic mass spectrometer (ESI). 1H, 13C and 31P NMR spectra were 
recorded on a Bruker Ascend 400 (400, 100 and 162 MHz, respectively) spectrometer. Time-
dependent 31P NMR for dephosphorylation process was recorded on a JEOL 600 MHz NMR (243 
MHz). TEM micrographs were obtained on a JEM-1230R Transmission Electron Microscope. 
SEM micrographs were measured on a FEI Quanta 250 FEG Scanning Electron Microscope. 
Confocal images were obtained on a Zeiss LSM780 Confocal Microscope. The fluorescence 
intensity of PI was detected using imaging flow cytometer (ImageStream X Mark, Germany). 
LDH release was determined using a Tecan Infinite M1000 PRO microplate reader. 
Synthesis. Synthetic procedures and characterizations of surface ligands applied in this study 
are described in Supporting Information.  
TEM imaging. Aliquots (10 μL) of sample solution were added into a glow discharge copper 
grid (400 mesh) coated with thin carbon film and incubated for 30 s at room temperature. After 
removing excess solution, the grid was washed with deionized water three times and then stained 
with 2.0% (w/v) uranyl acetate (UA) by exposing the grid in three drops of UA solution for 30 s. 
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TEM images were captured at high vacuum on transmission electron microscope JEM-1230R 
(JEOL, Japan). 
Molecular dynamics simulations and polymorph prediction. Molecular mechanics 
calculations were performed using Materials Studio. As the crystal structure prediction method 
uses a rigid body approximation in the initial search for crystal packing alternatives, it is 
necessary to perform an analysis to determine low energy geometry to be used as input for the 
packing calculations. The molecules were drawn and geometrical energy minimization scans 
were performed using Forcite module of Materials Studio. The optimized low energy 
conformations were used as the starting points for crystal structure prediction using the Materials 
Studio Polymorph Predictor (PP).  
Cell viability assay. Cells in exponential growth phase were seeded in a 96 well plate at a 
concentration of 7×103 cells/well for HeLa, A375, and 1×104 cells/well for HS5, OVCAR3, cell 
lines. The cells were allowed to attach to the wells for 12 h at 37ºC, 5% CO2. The culture 
medium was removed followed by addition of 100 μL culture medium containing different 
concentrations (0.1, 1, 10, 100 and 200 μM) of compound 2 (immediately diluted from 10 mM 
stock solution in PBS buffer). After the desired time of exposure, 10 μL MTT solution (5 
mg/mL) was added to each well and incubated at 37°C for another 4 h, and then 100 μL of SDS 
solution (10% in Milli-Q water) was added to stop the reduction reaction and dissolve the purple 
formazan. The absorbance of each well at 570 nm was measured by a Tecan microplate reader. 
All experiments were conducted triplicate. The results were calculated as means, which are 
expressed as cell viability (%). 
Live Cell imaging. Molecular probes were purchased from Life Technologies (Thermo Fisher 
Scientific, USA). Cells in exponential growth phase were seeded into a glass bottomed culture 
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dish at 2×105 cells per dish. The cells were allowed for attachment for 24 h at 37 °C under 5% 
CO2. Culture medium was removed and fresh medium containing different concentrations of 
compounds was added. After incubation for desired time, cells were washed with live cell 
imaging solution for three times, and further stained with commercial cell labels. Cells were then 
washed two times with fresh live-cell imaging solution and visualized by laser confocal 
microscopy (LSM 780, Carl Zeiss) immediately (λex: 405 nm for compound 2, 488 nm for 
Lysotracker Green DND-26, 561 nm for Actinred 555 and Alexa Fluor 555, 633 nm for 
CellMask deep red; λem: 420-480 nm for compound 2, 508-570 nm for Lysotracker Green DND-
26, 580-720 nm for Actinred 555, 570-606 nm for Alexa Fluor 555, 650-750 nm for CellMask 
deep red). 
SEM imaging. After taking confocal images, the samples were washed with PBS and then the 
cells were cross-linked with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 10 min. The 
samples were washed with 0.1 M cacodylate buffer for 5 min (×3) and then further fixed with 
1% osmium tetroxide in 0.1 M cacodylate buffer for 30 min, followed by washing with water for 
5 min (×3) and then progressive dehydration in a graded series of ethanols (70%, 80%, 90%, 
95% and twice in 100%, 3 minutes at each concentration). The cells were rinsed with t-butanol 
for 3 min (×3) and then dried by freeze-dryer overnight. SEM images of the dried samples were 
captured before platinum coating. 
LDH release. LDH release activity was measured by pierce LDH cytotoxicity assay kit 
(Thermo Scientific) according to the manufacturers’ instructions. HeLa, A375 and OVCAR3 
cells were seeded at 1.5 ×104 cells/well in 100 μL of medium in a 96 well plate, respectively. 
After incubation with compound 2 (10, 50, 100 μM) for 12 h, the release of LDH in the 
supernatant was measured with a microplate reader at 490 nm. Cells treated with 10 μL of water 
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(12 h) or Lysis buffer (10X, 45 min) was used as negative and positive controls, respectively. All 
experiments were carried out in triplicates. LDH activity was calculated as follows: 
LDH	release	(%) = 	Compound	treated	activity − Negative	activityPositive	activity − Negative	activity 	× 100 
 
RESULTS AND DISCUSSION 
Molecular design and synthesis.1,10-phenanthroline analogous containing two bidentates 
were reported as optimal ligands in the preparation of multinuclear cyclic pseudorotaxanes as 
¢muscle molecules¢ through metal(I)-mediated assembly because of their long linear length and 
highly rigidity. By replacing the polyethylene glycol macrocycle with two carboxyl groups, we 
were able to introduce enzyme responsive amino acids obtaining the target molecule 2 (Scheme 
1A). The synthesis commences with 2,9-dibromo-1,10-phenanthroline and 3,8-dibromo-1,10-
phenanthroline both prepared from 1,10-phenanthroline through different paths (Scheme S1 and 
S2). Following Sauvage’s method, we were able to apply 2,9-dibromo-1,10-phenanthroline and 
methyl 4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate for Suzuki-coupling obtaining the 
dione building block in elevated yield (84%). The linear aldehyde building block was prepared in 
5 steps from 3,8-dibromo-1,10-phenanthroline. A condensation of both building blocks at the 
presence of ammonium acetate in a sealed tube at 105oC for 24 h constructed an oxazole ring as 
rigid spacer leading to molecule 1 identified by high-resolution mass spectroscopy (HRMS). 
Two carboxyl groups of the rigid molecule 1 were activated with diisopropylcarbodiimide (DIC) 
and N-hydroxysuccinimide (NHS), following the conjugation with two o-phospho-L-tyrosine 
(Yp) forming the soluble precursor 2. Upon the expression of alkaline phosphatase (ALP), the 
precursor 2 transforms into 3, the hydrophobic monomer ready for self-assembly.  
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The geometrical energy minimized structures of 2 and 3 (Scheme 1B) indicate both molecules 
adopt Y-shape with linear length of hydrophobic domain beyond 30 Å,1 longer than the thickness 
of the hydrophobic core of cell membrane. The hydrophobic domains of both molecules remain 
static without deformation during ALP induced dephosphorylation due to the extreme rigidity, 
which may lead to efficient membrane insertion. 
 
 
 
 
Scheme 1. (A) The synthetic path of precursor 2, and the enzyme triggered transformation of 2 
into monomer of self-assembly 3. (B) The stick models of geometrical energy minimized 
structures of 2 and 3.  
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ALP induced molecular self-assembly. The ALP instructed transformation of 2 into 3 was 
monitored by 31P NMR (Figure 2A).17 The time-lapse spectra indicated that after 90 min 
incubation with ALP (Figure S1B), a complete conversion of 2 to 3 is reached. Time-lapse 
emission spectroscopies (Figure 2B and S1) indicate the decrease of emission intensity during 
the first 60-min incubation induced by self-quenching. After that, the intensity gradually 
becomes stable. The two-stage migration of maximum emission peak, red shift until 60 min and 
blue shift afterwards, suggests a dynamic adjustment of molecular packing following the 
molecular transformation from 2 to 3. Regarding the rigidity of the molecule, the intermolecular 
π–π stacking is suggested as the main driving force for self-assembly resulting in the overall red 
shift (from 457nm to 475 nm) of emission spectra.  Optical images taken at the end-point of the 
transformation exhibit clear solutions with neither precipitation nor gel-formation observed. 
Under the UV light, the solution emits light blue fluorescence (Figure 2C and S2). The 
transmission electron microscopy (TEM) (Figure 2D and S2) confirms the self-assembly of 3 
into irregular nanoscale aggregates distributed in PBS buffer. The Polymorph Predictor module18 
predicts molecular self-assembly is driven by strong intermolecular π-π stacking (Figure 2E and 
Figure S3) forming close packed nanostructure with hydrophobic surface, which is consistent to 
the emission spectra variations.  
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Figure 2. (A) Time-lapse 31P NMR spectroscopies of 2 (400 μM ) in Tris-HCl D2O buffer 
(50mM, pH = 8.5) reacting with ALP (1 U/mL). Na2HPO4 (6mM) is used as internal standard. 
(B) Time-lapse normalized maximum emission intensity and wavelength of 2 (100 μM) in PBS 
buffer reacted with ALP (1 U/mL). Optical images under the normal light and UV light (365 nm) 
(C) and TEM image (D) of end-point of 2 (100 μM) reacted with ALP (1U/mL) in PBS buffer. 
(E) The predicted molecular stacking of 3 in CPK model correlated to the self-assemblies in 
TEM image.  
Membrane insertion induced toxicity in vitro. Three cancer cell lines, the cervical cancer 
cell (HeLa), the skin malignant melanoma cell (A375), the drug resistant ovarian cancer cell 
(OVCAR-3), and stromal cell line HS-5 cell with ALP isozymes in different expression patterns 
cultured in different concentrations of exogenous ALP (the ALP expression profiles are 
summarized in Table S1), are applied in cytotoxicity tests of 2 (Figure 3A). With no toxicity on 
HS-5 cells, cancerous cell targeted cytotoxicity of 2 is revealed. Cancerous cell viability profiles 
also suggested concentration dependent/cell type dependent toxicity of 2. 2 started showing 
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toxicity on HeLa cell beyond 10 μM. But it started showing toxicity on both A375 cell and 
OVCAR3 cell beyond 100 μM. At 200 μM, 2 had similar toxicity on both HeLa and A375 cells. 
And it killed 40% of the OVCAR3 cells after 3-day incubation.  
Live cell imaging by confocal microscopy exhibits toxicity correlated selective subcellular 
targeting. Towards cancerous cells, under compatible condition ([2] =10 μM), we observe blue 
fluorescence distributed mainly in lysosomes (Figure S4A). Accompanied with cytotoxicity, self-
assemblies start accumulating on cell membranes with stochastic distribution. Following the 
rising of toxicity, the population of targeted cell by self-assemblies rises (Figure S4B and S4C). 
Comparing to normal cell (HS-5)’s lysosome targeted accumulation of self-assemblies (Figure 
S5), precursor 2 selectively target cancerous cell membranes inducing toxicity. Fluorescent 
imaging along the z-axis (Figure 3B, 3C 3D and S6) reveals cancerous cell membrane insertion 
of self-assemblies. The fluorescent intensity profile along the cell membrane exhibiting 
enhancement of self-assemblies’ fluorescent intensity (blue) accompanied with decline of cell 
membrane’s fluorescent intensity (red) vice versa, confirms the membrane insertion of self-
assemblies on three types of cancerous cells. Under the same incubation condition, the 
membrane insertion rate in order from the highest to the lowest is HeLa cell, A375 cell and 
OVCAR-3 cell, consistent to the cytotoxicity profile of 2 towards these cancer cells. SEM 
images indicated microscale synthetic analogues inserting on membrane close to the cell margin 
of all three types of cancerous cells (Figure S7).  By increasing the incubation concentration of 2, 
expansion of assembled analogues on membrane is observed (Figure S4B and S4C). Scientists 
predicted the phospholipids exaction from membrane to inserted analogue due to the van der 
Waals and hydrophobic interactions during the late stage of insertion.19 We observed the same 
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phenomenon in the experiment that the membrane shifted toward self-assembled analogues 
(Figure S8). 
ALP guided membrane insertion in vitro. The non-selective membrane insertion on all three 
types of cancer cells with (HeLa) and without (A375 and OVCAR3) placental alkaline 
phosphatase (PLAP) expression suggests that overexpression of PLAP that locate on the 
membrane is not critical to self-assembly-facilitated membrane insertion here. After treatment of 
PLAP inhibitor L-phenylalanine, HeLa cells showed unaffected membrane insertion of assembled 
analogues (Figure S9). HeLa cell membrane insertions show no overlap with PLAP (Figure 4A) 
suggest no physical binding interactions between the PLAP and self-assemblies, which is 
different from PLAP guided self-assembly on cancer cell membrane showing co-localizations.4-5, 7-8, 
20-21 By removing the exogenous ALP in the culture medium, higher membrane insertion efficiency 
is observed (Figure S10). These experimental results indicate that the membrane insertion of 
self-assembled analogues is a consequence of collective influence of cancer cell released ALP, 
and the exogenous ALP. 
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Figure 3. (A) Cell viabilities of HeLa, A375, OVCAR3 and HS-5 cells treated with precursor 2 
at various concentrations. Confocal image (one section along the z-axis) and fluorescent intensity 
profile of HeLa (B), A375 (C) and OVCAR3 (D) cells treated with 2 (100 μM) for 24 h and 
stained with CellMask-deep red. The inlet picture in confocal image indicates the fluorescent 
intensity profile area by yellow line. In both confocal images and intensity profiles, blue 
represents self-assemblies and red represents plasma membrane.  
Selective membrane insertion in fluid phase. Heterogeneity is essence to membrane 
structure. Membrane lipids with varying lengths of hydrophobic portion adopt various fluid and 
solid phases through relatively loose packing with narrower hydrophobic core or tight packing 
with hydrophobic region in longer length, respectively.1 In model bilayer with coexisted fluid and 
solid phases, functional peptide or protein show clear preference for a particular phase. 
Therefore, besides physical properties alteration, membrane insertion into fluid phase or solid 
phase will induce remarkably different cellular biochemical transductions. To detect the 
specificity of membrane insertion, we apply lipid raft marker to label the solid phase of HeLa 
cell membrane after treatment with precursor 2. Imaging along the z-axis (Figure 4B and Figure 
S11) indicates that the self-assemblies selectively insert into fluid phase of membrane avoiding 
solid phase, the lipid rafts,22 which is different from the PLAP guided self-assembly reported 
previously.4, 23 This is confirmed by fluorescence intensity profile of the cell margin that exhibits 
enhancement of fluorescent intensity of self-assemblies (blue) accompanied with decline of 
fluorescent intensity of lipid rafts (green), vice versa (Figure 4B). 
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Figure 4. (A) Confocal images of HeLa cell treated with precursor 2 for 24 hours with PLAP 
labelling. (B) Confocal image (left) of HeLa cell treated with 2 (100 μM) for 24 h and stained 
with Lipid Raft Labeling (green), and fluorescent intensity profile (right) of self-assemblies 
(blue) and lipid rafts (green) along the cell margin indicated by red line in inlet confocal image. 
Self-assemblies are represented in blue. Membrane inserted matrix between rafts are indicated by 
light blue arrows. 
Membrane insertion induced permeability alteration. To study the membrane permeability 
alteration, the cellular uptake or release of small organic molecule, peptide and protein after 
membrane insertion were characterized. We selected 5-chloromethylfluorescein diacetate 
(CellTracker Green), fluorescently labeled phalloidin (ActinRed) and lactate dehydrogenase 
(LDH), representing the three types of molecules respectively. 
  We applied patch pipette tips tightly contacting the plasma membrane of cells with and without 
membrane insertion of self-assembly of 3 as shown in Figure 5A. By releasing the fluorescent 
CellTracker Green, we recorded the time-lapse intracellular fluorescent intensity as summarized 
in Figure 5A. Clearly, the membrane insertion results into inhibition of intracellular uptake of 
small organic molecules. ActinRed, as a live cell membrane impermeable bi-cyclic peptide, is 
applied in HeLa cell culture after cell incubation with 2 without fixing and permeabilizing the 
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cell. The confocal images (Figure 5B) show no intracellular actin stain after membrane insertion 
suggesting not only the peptide can’t pass through the inserted synthetic analogues, but also the 
un-inserted part of cell membrane is intact.  The co-localization of ActinRed with membrane 
inserted self-assembled analogues indicates the binding interactions between them. A negligible 
increase of LDH release was also observed in all the cancerous cells incubated with precursor 2 
at increasing concentrations for 12 h (Figure 5C).  
 
Figure 5. (A) Schematic illustration of protocol applied for cell uptake of CellTracker Green 
before and after membrane insertion (left) and the time-lapse intracellular fluorescent intensity 
profile (right) obtained by following the protocol. (B) Confocal images of HeLa cells treated 
with 2 (100 μM) for 24 h and stained with ActinRed without fixing and permeabilizing the cell. 
(C) Extracellular release of LDH in different cancerous cell lines after incubation with increasing 
concentrations of precursor 2 for 12 h. 
The experiment results indicate that the membrane insertion of self-assembled analogues alters 
the cell membrane permeability by blocking the intracellular uptake without general membrane 
disturbance. Eventually, the expansion of membrane insertion of synthetic analogues totally 
blocks the cell metabolism and leads to cell death. 
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CONCLUSIONS 
The application of extremely rigid molecule in tumour biomarker induced molecular self-
assembly successfully implements the cancer cell membrane insertion of synthetic micro-scale 
analogues in vitro. Interestingly, the self-assembled system only inserts into the fluid phase of 
cancerous cell membrane altering the membrane permeability. The selectivity and membrane 
insertion efficiency on several cancer cell lines demonstrate the potential of the design as 
anticancer strategy. On the other hand, the relatively mild cytotoxicity on certain cancer cell lines 
indicates the potential of subtle manipulation of cellular functions. The main challenges ahead 
are to comprehensively characterize the kinetics of this process and to modify the molecular 
design for cancer therapeutics. Undoubtedly, the study of cell response to membrane insertion of 
self-assemblies at molecular level will also facilitate the mechanism exploration of membrane 
repair and danger sensing. 
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